PIN6: ESTIMATED COSTS TO CONDUCT A PHASE III CLINICAL TRIAL OF A NEW PULMONARY TUBERCULOSIS DRUG
نویسندگان
چکیده
منابع مشابه
A STUDY OF MYCOBACTERIUM TUBERCULOSIS DRUG RESISTANCE IN PULMONARY TUBERCULOSIS
Tuberculosis remains a major public health problem in both developing and developed countries. Drug-resistant tuberculosis is an increasing health problem and serious challenge to tuberculosis (TB) control programs. Information about the susceptibility pattern of Mycobacterium tuberculosis isolates against anti-tuberculosis drugs is an important aspect to TB control. The objectives of the s...
متن کاملa study of mycobacterium tuberculosis drug resistance in pulmonary tuberculosis
tuberculosis remains a major public health problem in both developing and developed countries. drug-resistant tuberculosis is an increasing health problem and serious challenge to tuberculosis (tb) control programs. information about the susceptibility pattern of mycobacterium tuberculosis isolates against anti-tuberculosis drugs is an important aspect to tb control. the objectives of the study...
متن کاملPirfenidone in idiopathic pulmonary fibrosis: A phase III clinical trial in Japan
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease without proven effective therapy. A multi-centered, double-blind, placebo-controlled, randomized phase III clinical trial was conducted in Japanese patients with well-defined IPF to determine the efficacy and safety of pirfenidone, a novel antifibrotic, oral agent, over 52 weeks. Of total 275 patients randomized [high-dose (1800 ...
متن کاملEvaluation of Hepatoprotective Effect of Silymarin Among Under Treatment Tuberculosis Patients: A Randomized Clinical Trial
Hepatic toxicity is the most serious adverse effect of anti tuberculosis drugs. This study was performed to evaluate efficacy of silymarin as a hepatoprotective herbal agent. In a randomized double blind clinical trial 70 new cases of pulmonary tuberculosis were divided into two groups. The intervention group was assigned to receive silymarin and the control group received placebo. Tuberculosis...
متن کاملEvaluation of Hepatoprotective Effect of Silymarin Among Under Treatment Tuberculosis Patients: A Randomized Clinical Trial
Hepatic toxicity is the most serious adverse effect of anti tuberculosis drugs. This study was performed to evaluate efficacy of silymarin as a hepatoprotective herbal agent. In a randomized double blind clinical trial 70 new cases of pulmonary tuberculosis were divided into two groups. The intervention group was assigned to receive silymarin and the control group received placebo. Tuberculosis...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2001
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(11)71585-6